Sugen Uses Pangea's Tools To Reduce Redundancies | GenomeWeb

OAKLAND, Calif.--Sugen, a small molecule drug-discovery company wholly owned by Pharmacia and Upjohn, has licensed Pangea Systems' proprietary Clustering and Alignment Tools. Greg Plowman, Sugen's vice-president of molecular biology, said that the performance of Pangea's clustering tool on multiprocessor machines would allow Sugen to reduce the redundancies in its large sequence databases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.